Top compounds associated with response to RGL2


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.12 0.03
mRNA AZD6482 GDSC1000 pan-cancer AAC 0.076 0.03
mRNA CIL70 CTRPv2 pan-cancer AAC 0.11 0.03
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC -0.091 0.03
mRNA Pazopanib GDSC1000 pan-cancer AAC 0.08 0.03
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.3 0.03
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.077 0.03
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.03
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.078 0.03
mRNA narciclasine CTRPv2 pan-cancer AAC -0.078 0.04
Download CSV